News Novo Nordisk A/S Börse Stuttgart

Equities

NOVA

US6701002056

Market Closed - Börse Stuttgart Other stock markets 16:27:00 02/07/2024 BST			5-day change	1st Jan Change
133 ^EUR	-2.21%		+3.03%	+45.92%

07-02	Tesla, megacaps drive S&P 500, Nasdaq higher; rates outlook in focus	RE
07-02	Novo Nordisk, Eli Lilly Charging 'Unconscionably' High Prices, Biden, Sanders Say	MT

Summary

Unlock all the news: Be the first to know and act before the market!

100% Free Registration

Tesla, megacaps drive S&P 500, Nasdaq higher; rates outlook in focus	07-02	RE
Novo Nordisk, Eli Lilly Charging 'Unconscionably' High Prices, Biden, Sanders Say	07-02	MT
Top Midday Stories: Tesla, GM Report Vehicle Deliveries; Biden, Sanders Say Novo Nordisk, Eli Lilly Charge 'Unconscionably' High Prices; Warner Bros. Interested in Deal With Paramount	07-02	MT
US President Calls Out Eli Lilly, Novo Nordisk Over High Drug Prices	07-02	MT
Wall St edges lower as Powell signals caution; Tesla jumps after delivery data	07-02	RE
US FDA warns website over unlawful sale of weight-loss drugs	07-02	RE
Novo Holdings invests in MATR Foods expansion within plant-based fungi food	07-02	AQ
Sector Update: Health Care Stocks Lean Lower Premarket Tuesday	07-02	MT
Wall St set for lower open as megacaps retreat with jobs data, Powell in focus	07-02	RE
Novo Nordisk, Eli Lilly Charging 'Unconscionably' High Prices, Biden, Sanders Say	07-02	MT
Biden says Novo Nordisk must cut prices of diabetes, weight loss drugs	07-02	RE
Novo Nordisk, Eli Lilly Charging 'Unconscionably' High Prices, Biden, Sanders Say in USA Today Op-Ed	07-02	MT
NOVO NORDISK : Jefferies reiterates its Sell rating	07-02	ZD
Indices: CAC relaxes, Merval soars	07-02
Momentum Picks Q3 2024: 5 stocks for the summer	07-01
Novo Nordisk A/S - share repurchase programme	07-01	GL
India panel urges drug regulator to approve Lilly's obesity drug Mounjaro	07-01	RE
New semester, new state of mind	07-01
India plans incentives for diabetes, obesity drug makers in 2026, government official says	06-28	RE
NOVO NORDISK : UBS gives a Neutral rating	06-28	ZD